Highlights
- Market Cap
- $146.02M
- Enterprise Value
- $112.85M
- EPS (TTM)
- -$0.87
- Total Revenue (TTM)
- $12.30M
- Gross Profit (TTM)
- -$12.16M
- EBITDA (TTM)
- -$44.73M
- Year Range
- $2.11 - $5.86
- Target Price
- $18.00
- ROA (TTM)
- -31.64%
- ROE (TTM)
- -35.55%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Nano-X Imaging Ltd., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Nano-X Imaging Ltd. (NNOX) has returned -18.93% so far this year and -54.55% over the past 12 months.
Nano-X Imaging Ltd.
- 1D
- 3.18%
- 1M
- -4.22%
- YTD
- -18.93%
- 6M
- -38.65%
- 1Y
- -54.55%
- 3Y*
- -26.73%
- 5Y*
- -44.03%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Aug 21, 2020, NNOX's average daily return is +0.03%, while the average monthly return is +0.97%. At this rate, your investment would double in approximately 6.0 years.
Historically, 37% of months were positive and 63% were negative. The best month was May 2023 with a return of +191.2%, while the worst month was Feb 2021 at -40.3%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 5 months.
On a daily basis, NNOX closed higher 45% of trading days. The best single day was May 1, 2023 with a return of +68.4%, while the worst single day was Sep 17, 2020 at -23.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.50% | -13.19% | -4.22% | -18.93% | |||||||||
| 2025 | 1.11% | -14.97% | -19.31% | 0.70% | 1.79% | 0.98% | -8.90% | -17.83% | -4.39% | -1.89% | 23.42% | -37.50% | -61.11% |
| 2024 | -14.60% | 105.15% | -12.46% | -8.29% | -6.70% | -12.20% | 17.44% | -26.10% | -4.55% | -6.74% | 13.93% | 11.46% | 13.03% |
| 2023 | 24.93% | -20.93% | -20.85% | 5.89% | 191.16% | -12.93% | -19.95% | -32.86% | -21.20% | -23.02% | 32.67% | -4.93% | -13.69% |
| 2022 | -21.94% | -10.57% | 6.80% | -15.22% | 11.21% | 10.57% | 6.55% | 10.55% | -13.82% | 23.80% | -25.00% | -30.70% | -49.24% |
| 2021 | 65.97% | -40.26% | -8.44% | -19.06% | -25.48% | 28.20% | -11.54% | -13.02% | -8.76% | 0.67% | -8.92% | -29.52% | -68.16% |
Benchmark Metrics
Nano-X Imaging Ltd. has an annualized alpha of -15.14%, beta of 1.76, and R² of 0.09 versus S&P 500 Index. Calculated based on daily prices since August 24, 2020.
- This stock participated in 200.61% of S&P 500 Index downside but only 24.68% of its upside — more exposed to losses than it benefited from rallies.
- R² of 0.09 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -15.14%
- Beta
- 1.76
- R²
- 0.09
- Upside Capture
- 24.68%
- Downside Capture
- 200.61%
Return for Risk
Risk / Return Rank
NNOX ranks 8 for risk / return — in the bottom 8% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Nano-X Imaging Ltd. (NNOX) and compare them to a chosen benchmark (S&P 500 Index).
| NNOX | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.81 | 0.90 | -1.70 |
Sortino ratioReturn per unit of downside risk | -1.34 | 1.39 | -2.72 |
Omega ratioGain probability vs. loss probability | 0.86 | 1.21 | -0.35 |
Calmar ratioReturn relative to maximum drawdown | -0.91 | 1.40 | -2.30 |
Martin ratioReturn relative to average drawdown | -1.60 | 6.61 | -8.21 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore NNOX risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Nano-X Imaging Ltd.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Nano-X Imaging Ltd. was 97.61%, occurring on Feb 12, 2026. The portfolio has not yet recovered.
The current Nano-X Imaging Ltd. drawdown is 97.46%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.61% | Jan 28, 2021 | 1267 | Feb 12, 2026 | — | — | — |
| -63.36% | Sep 14, 2020 | 13 | Sep 30, 2020 | 77 | Jan 21, 2021 | 90 |
| -14.29% | Aug 26, 2020 | 2 | Aug 27, 2020 | 3 | Sep 1, 2020 | 5 |
| -8.54% | Sep 3, 2020 | 2 | Sep 4, 2020 | 1 | Sep 8, 2020 | 3 |
| -0.54% | Jan 22, 2021 | 1 | Jan 22, 2021 | 1 | Jan 25, 2021 | 2 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Nano-X Imaging Ltd. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Nano-X Imaging Ltd. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for NNOX relative to other companies in the Medical Devices industry. Currently, NNOX has a P/S ratio of 11.8. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for NNOX in comparison with other companies in the Medical Devices industry. Currently, NNOX has a P/B value of 0.9. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |